We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+3.84%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.5B
AUM Growth
-$1.93B
(-10%)
Cap. Flow
-$2.26B
Cap. Flow
% of AUM
-13.67%
Top 10 Holdings %
Top 10 Hldgs %
16.19%
Holding
1,547
New
416
Increased
366
Reduced
319
Closed
426
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$233M |
| 2 |
TSMC
TSM
|
+$222M |
| 3 |
Philip Morris
PM
|
+$189M |
| 4 |
Qualcomm
QCOM
|
+$171M |
| 5 |
AstraZeneca
AZN
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$396M |
| 2 |
Citigroup
C
|
+$269M |
| 3 |
Cisco
CSCO
|
+$253M |
| 4 |
Boeing
BA
|
+$166M |
| 5 |
Bank of America
BAC
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.96% |
| 2 | Technology | 21.61% |
| 3 | Consumer Staples | 8.79% |
| 4 | Communication Services | 8.54% |
| 5 | Financials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MJN
176
DELISTED
Mead Johnson Nutrition Company
MJN
| $19.8M | 0.12% |
+238,390
| New | +$19.3M |
|
177
McKesson
MCK
$101B
| $19.6M | 0.12% |
111,001
-141,045
| -56% | -$24.6M |
|
|
ORAN
178
DELISTED
Orange
ORAN
| $19.3M | 0.12% |
1,315,657
-1,105,757
| -46% | -$14.4M |
|
179
Andersons Inc
ANDE
$2.22B
| $19.3M | 0.12% |
324,942
+85,471
| +36% | +$4.79M |
|
180
Ameren
AEE
$30.1B
| $19.2M | 0.12% |
+465,576
| New | +$17.9M |
|
|
CPHD
181
DELISTED
Cepheid Inc
CPHD
| $18.9M | 0.11% |
366,415
+348,387
| +1,932% | +$17.7M |
|
182
Kimberly-Clark
KMB
$36.5B
| $18.9M | 0.11% |
+178,700
| New | +$18.5M |
|
183
Unum
UNM
$14.3B
| $18.8M | 0.11% |
531,182
-253,754
| -32% | -$8.66M |
|
|
LXK
184
DELISTED
Lexmark Intl Inc
LXK
| $18.7M | 0.11% |
405,000
-183,218
| -31% | -$7.35M |
|
185
Check Point Software Technologies
CHKP
$13.1B
| $18.4M | 0.11% |
272,531
+214,336
| +368% | +$14.2M |
|
|
HSP
186
DELISTED
HOSPIRA INC
HSP
| $18.2M | 0.11% |
420,776
+224,057
| +114% | +$9.61M |
|
|
RKT
187
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $18.1M | 0.11% |
342,426
+58,876
| +21% | +$3.08M |
|
|
GMCR
188
DELISTED
KEURIG GREEN MTN INC
GMCR
| $18.1M | 0.11% |
170,950
+110,495
| +183% | +$11M |
|
189
Annaly Capital Management
NLY
$17.4B
| $17.8M | 0.11% |
406,698
+385,470
| +1,816% | +$16.7M |
|
190
Synaptics
SYNA
$4.15B
| $17.8M | 0.11% |
297,154
+23,177
| +8% | +$1.38M |
|
|
WFM
191
DELISTED
Whole Foods Market Inc
WFM
| $17.8M | 0.11% |
351,514
+342,905
| +3,983% | +$18.3M |
|
|
BHI
192
DELISTED
Baker Hughes
BHI
| $17.8M | 0.11% |
273,351
+120,533
| +79% | +$7.13M |
|
|
SYA
193
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $17.7M | 0.11% |
892,075
+131,490
| +17% | +$2.54M |
|
194
National Grid
NGG
$81.3B
| $17.6M | 0.11% |
+265,638
| New | +$17.1M |
|
|
BRSL
195
Brightstar Lottery PLC
BRSL
$2.03B
| $17.5M | 0.11% |
1,241,859
-1,559,734
| -56% | -$24.1M |
|
|
RFP
196
DELISTED
Resolute Forest Products Inc.
RFP
| $17.4M | 0.11% |
864,223
+337,603
| +64% | +$6.47M |
|
197
Thermo Fisher Scientific
TMO
$220B
| $17.3M | 0.1% |
+143,747
| New | +$17.1M |
|
198
Alkermes
ALKS
$8.25B
| $17.1M | 0.1% |
388,629
+315,556
| +432% | +$15M |
|
199
Advanced Micro Devices
AMD
$789B
| $16.9M | 0.1% |
4,209,912
+2,165,845
| +106% | +$8.27M |
|
200
Lam Research
LRCX
$390B
| $16.6M | 0.1% |
3,021,260
-570,790
| -16% | -$3.03M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2014 Portfolio in Review
As of Q1 2014, Arrowstreet Capital held 1,547 positions worth $16.5B, down 10% from $18.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Arrowstreet Capital withdrew a net $2.26B in Q1 2014, closing 426 positions and reducing 319 holdings. Its most notable exit was GE Aerospace, an estimated $151M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Arrowstreet Capital opened a new position in Philip Morris worth $192M.
- Arrowstreet Capital's largest Q1 2014 buy was Philip Morris: 2,344,576 shares worth $192M.
- Arrowstreet Capital added most to GSK in Q1 2014, an estimated $233M increase.
- Arrowstreet Capital's biggest Q1 2014 reduction was Vodafone, cutting an estimated $396M.
- Arrowstreet Capital fully exited GE Aerospace in Q1 2014, selling an estimated $151M.
- Arrowstreet Capital's ten largest holdings make up 16% of its $16.5B portfolio in Q1 2014.
- Arrowstreet Capital opened 416 new positions and closed 426 in Q1 2014.
- Arrowstreet Capital's portfolio value fell 10% quarter-over-quarter to $16.5B.
Based on Arrowstreet Capital's 13F filing for Q1 2014, filed 15 May 2014.